7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia.

      International Journal of Gynaecology and Obstetrics
      Adolescent, Data Interpretation, Statistical, Double-Blind Method, Female, Follow-Up Studies, Humans, Pre-Eclampsia, prevention & control, Pregnancy, Risk Factors, Ubiquinone, analogs & derivatives, therapeutic use, Vitamins, Young Adult

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess whether supplementation with Coenzyme Q10 (CoQ10) during pregnancy reduces the risk of pre-eclampsia. Women at increased risk of pre-eclampsia were enrolled in a randomized, double-blind, placebo-controlled trial. Women were assigned to receive 200 mg of CoQ10 or placebo daily from 20 weeks of pregnancy until delivery. The primary outcome was rate of pre-eclampsia. Statistical analyses were by intention-to-treat. Of the 235 women enrolled in the trial, 118 were randomized to receive CoQ10 and 117 received a placebo. A total of 197 (83.8%) women were followed-up. The overall rate of pre-eclampsia was 20% (n=47). Thirty women (25.6%) in the placebo group developed pre-eclampsia compared with 17 women (14.4%) in the CoQ10 group, and this reduction was significant (P=0.035) (relative risk [RR] 0.56; 95% confidence interval [CI], 0.33-0.96). Supplementation with CoQ10 reduces the risk of developing pre-eclampsia in women at risk for the condition.

          Related collections

          Author and article information

          Comments

          Comment on this article